Evidence map›Paper›PMID 34930410›Full record

ArticleTrials2021

A cross-sectional survey of potential factors, motivations, and barriers influencing research participation and retention among people who use drugs in the rural USA.

Angela T Hetrick, April M Young, Miriam R Elman, Sarann Bielavitz, Rhonda L Alexander, Morgan Brown, Elizabeth Needham Waddell, P Todd Korthuis, Kathryn E Lancaster

Erratum issuedAbstract read
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Interventions to reduce self-stigma in people who use drugs: A systematic review.Journal of substance use and addiction treatment · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Intersectionality-Informed HIV Cure-Related Research at the End of Life: A Call to Action.International journal of environmental research and public health · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. "I'm tired of seeing my friends die": Barriers and facilitators to participating in clinical trials among rural people who use drugs in the United States.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Angela T HetrickDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, USA. hetrick.124@osu.edu.ORCID http://orcid.org/0000-0002-2951-051X
April M YoungDepartment of Epidemiology, University of Kentucky, Lexington, USA.
Miriam R ElmanOregon Health & Science University-Portland State University School of Public Health, Portland, USA.
Sarann BielavitzOregon Health & Science University-Portland State University School of Public Health, Portland, USA.
Rhonda L AlexanderDepartment of Epidemiology, University of Kentucky, Lexington, USA.
Morgan BrownDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, USA.
Elizabeth Needham WaddellOregon Health & Science University-Portland State University School of Public Health, Portland, USA.
P Todd KorthuisOregon Health & Science University-Portland State University School of Public Health, Portland, USA.
Kathryn E LancasterDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, USA.

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)U01TR002631 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD, YOUNG, APRIL MARIE · 2018 to 2023
$5.2M
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)UH3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2019 to 2022
$4.4M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia.K01DA048174 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LANCASTER, KATHRYN ELIZABETH · 2019 to 2023
$841k
NCATS NIH HHS U01 TR002631NCATS NIH HHS U01TR002631NIDA NIH HHS K01 DA048174NIDA NIH HHS K01DA048174NIDA NIH HHS UG1 DA015815NIDA NIH HHS UG1DA015815NIDA NIH HHS UG3 DA044798NIDA NIH HHS UH3 DA044798NIDA NIH HHS UH3DA044798NIDA NIH HHS UH3 DA044831NIDA NIH HHS UH3DA044831
6 · The paper itself

Abstract

backgroundDespite high morbidity and mortality among people who use drugs (PWUD) in rural America, most research is conducted within urban areas. Our objective was to describe influencing factors, motivations, and barriers to research participation and retention among rural PWUD.

methodsWe recruited 255 eligible participants from community outreach and community-based, epidemiologic research cohorts from April to July 2019 to participate in a cross-sectional survey. Eligible participants reported opioid or injection drug use to get high within 30 days and resided in high-needs rural counties in Oregon, Kentucky, and Ohio. We aggregated response rankings to identify salient influences, motivations, and barriers. We estimated prevalence ratios to assess for gender, preferred drug use, and geographic differences using log-binomial models.

resultsMost participants were male (55%) and preferred methamphetamine (36%) over heroin (35%). Participants reported confidentiality, amount of financial compensation, and time required as primary influential factors for research participation. Primary motivations for participation include financial compensation, free HIV/HCV testing, and contribution to research. Changed or false participant contact information and transportation are principal barriers to retention. Respondents who prefer methamphetamines over heroin reported being influenced by the purpose and use of their information (PR = 1.12; 95% CI: 1.00, 1.26). Females and Oregonians (versus Appalachians) reported knowing and wanting to help the research team as participation motivation (PR = 1.57; 95% CI: 1.09, 2.26 and PR = 2.12; 95% CI: 1.51, 2.99).

conclusionsBeyond financial compensation, researchers should emphasize confidentiality, offer testing and linkage with care, use several contact methods, aid transportation, and accommodate demographic differences to improve research participation and retention among rural PWUD.

Indexed as

MotivationPharmaceutical PreparationsCross-Sectional StudiesHumansKentuckyMaleOhioPharmaceutical PreparationsInjection drug useOpioidParticipant retentionRecruitmentRuralSubstance use

Identifiers

PMID34930410
PMCPMC8690874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.